Graham McIlroy

University of Birmingham - Institute of Cancer and Genomic Sciences

Birmingham

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

1,138

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 971 (35,168)
Citation 3

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody

2.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, Government of the United Kingdom - University Hospitals Birmingham, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 154 (276,121)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

3.

Vaccine Subtype and Dose Interval Determine Immunogenicity of Primary Series COVID-19 Vaccines in Older People

Number of pages: 29 Posted: 27 Apr 2022
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 13 (800,189)

Abstract:

Loading...

COVID-19, vaccines, elderly, primary series, BNT162b2, ChAdOx1